Skip to main content
Figure 4 | BMC Musculoskeletal Disorders

Figure 4

From: 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption

Figure 4

Influence of 1,25(OH) 2 D 3 therapy on parameters of bone formation measured by tetracylin labeling (secondary spongiosa of the right tibia head – arthritic joint) in AIA of the rat. Mineralizing surface (A), mineral apposition rate (B) and bone formation rate (C) were unaffected by AIA. Treatment with 1,25(OH)2D3 resulted in a highly significant increase of mineral apposition rate and bone formation rate and a significant increase in mineralizing surface compared with vehicle-treated AIA and healthy controls. ***p < 0.001; *p < 0.05 vs. AIA + vehicle; +++p < 0.001; ++p < 0.01 vs. healthy controls.

Back to article page